·
A. Ciampi, R.S. Bush, M. Gospodarowicz et al.
An
approach to classifying prognostic factors related to survival experience for
non-Hodgkin’s lymphoma patients: Based on a series of 982 patients:
1967-1975
Cancer
1981; 47: 621-627
·
T. Anderson, B.A. Chabner, R.C. Young et al.
Malignant
lymphoma I. The histology and staging of 473 patients at the National Cancer
Institute.
Cancer 1982; 50: 2699-2707
·
T. Anderson, V.T. De Vita, R.M. Simon et al.
Malignant
lymphoma II. Prognostic factors and response to treatment of 473 patients at
the National Cancer Institute.
Cancer
1982; 50: 2708-2721
·
R. Bartl, B. Frisch, R. Burkhardt, et al.
Assessment
of bone marrow histology in the malignant lymphomas (non Hodgkin’s):
correlation with clinical factors for diagnosis, prognosis, classification and
staging.
Br
J Haematol 1982; 51: 511-530
·
R.A. Rudders, R.A. Delellis, E.T. Ahl et al.
Adult
non Hodgkin’s lymphoma. Correlation of cell surface marker phenotype with
prognosis, the new working formulation, and the Rappaport and Lukes-Collins
histomorphologic schemes.
Cancer
1983; 52: 2289-2299
·
L. Danieu, G. Wong, B. Koziner et al.
Predictive
model for prognosis in advanced diffuse histiocytic lymphoma
Cancer
Research 1986; 46: 5372-5379
·
S. Jagannath, W.S. Velasquez, S.L. Tucker et
al.
Tumor
burden assessment and its implications for a prognostic model in advanced
diffuse large cell lymphoma
J
Clin Oncol 1986; 4: 859-865
·
A. Pereira y E. Montserrat
Linfomas no hodgkinianos: interés de
los factores pronósticos en las decisiones terapéuticas.
Med
Clin (Bar) 1988; 91: 172-174
·
F. Swan, W.S. Velasquez, S. Tucker et al.
A
New serologic staging system for large-cell lymphomas based on initial ß2-microglobulin
and lactate dehydrogenase levels
J
Clin Oncol 1989; 7: 1518-1527
·
W.S. Velasquez, S. Jagannath, S.L. Tucker et al.
Risk
classification as the basis for clinical staging of diffuse large-cell
lymphoma derived from 10-year survival data
Blood
1989; 74: 551-557
·
B. Coiffier and E. Lepage
Prognosis
of aggressive lymphomas: a study of five prognostic models with patients
included in the LNH-84 regimen
Blood
1989; 74: 558-564
·
B. Coiffier, C. Gisselbrecht, J.M. Vose et al.
Prognostic
factors in aggressive malignant lymphomas: description and validation of a
prognostic indexthat could identify patients requiring a more intensive
therapy
J
Clin Oncol 1991; 9: 211-219
·
M.N. Levine, G.P. Browman, M. Gent et al.
When
is a prognostic factor useful?: A guide for the perplexed
J
Clin Oncol 1991; 9: 348-356
·
J. Rodríguez-Díaz-Pavón, F. Cabanillas
Aspectos clínico-biológicos y
factores pronósticos de los linfomas no Hodgkin de estirpe B.
EIAH, Universidad de Salamanca, 1992.
Pág 423-439
·
J. Feliu, J.I. Chacón, P. Zamora
Factores pronósticos en oncología
Oncología clínica. Ed Interamericana
McGraww-Hill, 1992. Pag 179-188
·
The international non Hodgkin’s lymphoma
prognostic factor project
A
predictive model for aggressive non-Hodgkin’s lymphoma
N
Engl J Med 1993; 329: 987-994
·
C. Besses, J Sans-Sabrafén
Linfomas no hodgkinianos: estudio de
extensión, factores pronósticos y tratamiento
Hematología clínica. Ed Mosby Doyma
1994. Pag 387-402
·
M. Gonzalez Barón
Importancia de los factores pronósticos
en oncología.
Factores pronósticos en oncología. Ed.
Interamericana McGraw-Hill, 1994.Pág. 1-17
·
J.J. Sánchez Hernández, M.L. García de Paredes
Estudio de identificación de factores
pronósticos. Un enfoque estadístico
Factores pronósticos en oncología. Ed.
Interamericana McGraw-Hill,1994 Pag 22-53
·
E. Espinosa, P. Zamora, M. González Barón
Factores pronósticos y de predicción
de la respuesta en los lionfomas de alto grado.
Factores pronósticos en oncología. Ed.
Interamericana McGraw-Hill, 1994. Pag
367-376
·
P. Zamora, E. Espinosa, A. Ordóñez
Factores pronósticos en linfomas de
bajo grado
Factores pronósticos en oncología. Ed.
Interamericana McGraw-Hill, 1994. Pag
379-389
·
T.P. Miller, T.M. Grogan, S. Dahlberg et al.
Prognostic
significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin’s
lymphomas: a prospective Southwest Oncology Group trial
Blood
1994; 83: 1460-1466
·
Y. Bastion and B. Coiffier
Is
the International Prognostic Index for aggressive lymphoma patients useful for
follicular lymphoma patients? –Editorial-
J
Clin Oncol 1994; 12: 1340-1342
·
A. López-Guillermo, E. Montserrat, F. Bosch et
al.
Applicability
of the International Index for aggressive lymphomas to patients with low-grade
lymphoma
J
Clin Oncol 1994; 12: 1343-1348
·
M. French, J.P. Magaud, P. French et al.
Heterogeneity
of neolastic and reactive cell proliferation in non-Hodgkin’s lymphomas
linked to patients survival
Am
J Clin Pathol 1994; 101: 413-420
·
M.A. Shipp
Prognostic
factors in aggressive non-Hodgkin’s lymphoma: who has “high-risk disease?
Blood 1994; 83: 1165-1173
·
J.F. Seymour, M. Talpaz, F. Cabanillas et al.
Serum
interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma
J
Clin Oncol 1995; 13: 575-582
·
J. Hermans, A.D.G. Krol, K. Van Groningen et
al.
International
Prognostic Index for agressive non-Hodgkin’s lymphoma is valid for all
malignancy grades
Blood 1995; 86: 1460-1463
·
M.A. Gandarillas, E. Conde, F. Mazorra et
al.
Investigación de factores pronósticos
en linfomas de células grandes
Med
Clin (Barc) 1995; 104: 601-607
·
W. Hiddemann, D.L. Longo, B. Coiffier et al.
Lymphoma
classification – The gap between biology and clinical management is closing
Blood
1996; 88: 4085-4089
·
J.N. Winter, J. Andersen, D. Variakojis et al.
Prognostic
implications of ploidy and proliferative activity in the diffuse, agressive
non-Hodgkin’s lymphomas
Blood
1996; 88: 3919-3925
·
I. Christiansen, C. Gidlöf, K.M. Kälkner et
al.
Elevated
serum levels of soluble ICAM-1 in non-Hodgkin’s lymphomas correlate with
tumor burden, disease activity and other prognostic markers.
Br J Haematol 1996; 92: 639-646
·
J. Gómez Codina
Factores pronósticos de los LNH
Linfomas B y T. Biología, clínica y
tratamiento. Ed. IDEPSA, 1997. Pág 152-186
·
R. Kurzrock
Cytokine
deregulation in hematological malignances: clinical and biological
implications
Clin
Cancer Res 1997; 3: 2581-2584
·
M.M. Morente
Factores pronósticos en los linfomas
no hodgkinianos
Quinto curso de Hematopatología.
Tortosa, ICS, 1998. Pág. 131-152
·
J.M. Vose
Current
approaches to the management of non-Hodgkin’s lymphoma
Semin
Oncol 1998; 25: 483-491
·
A. López-Guillermo,
F. Cabanillas, P.McLaughlin et al.
Thed.
clinical significance of molecular response in indolent follicular lymphomas
Blood
1998; 91: 2955-2960
·
D.F. Moore, F. Cabanillas
Overview
of prognostic factors in non-Hodgkin’s lymphoma
Oncology
(Huntingt) 1998; 12: 17-24
·
F. Bertolini, M. Paolucci, F. Peccatori et al.
Angiogenic
growth factors and endostatin in non-Hodgkin’s lymphoma
Br J Haematol 1999; 106: 504-509
·
N. Niitsu, K. Sasaki, M. Umeda
A
high serum soluble Fas / APO-1 levelis associated with a poor outcome of
aggressive non-Hodgkin’s lymphoma
Leukemia 1999; 13: 1434-1440
·
A. Cuneo, R. Bigoni, G.M. Rigolin
Cytogenetic
profile of lymphoma of follicle mantle lineage: correlation with
clinicobiologic features
Blood
1999; 93; 1372-1380
·
Prognostic factors in non-Hodgkin’s lymphoma
(Symposium)
Rev
Esp Patol 1999; 32: 305-310
·
G. Gaidano, D. Capello, A. Gloghini et al.
Frequent
mutation of bcl-6 proto-oncogene in high grade, but no low grade, MALT
lymphomas of the gastrointestinal tract
Haematologica 1999; 84: 582-588
